Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-02
2007-01-02
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S333000, C514S340000, C514S342000, C546S255000, C546S256000, C546S268100, C546S269700
Reexamination Certificate
active
10646348
ABSTRACT:
The present invention relates to pyridyl substituted heterocycles and hydro isomers thereof and pharmaceutical compositions thereof that inhibit replication and/or proliferation of HCV virus. The present invention also relates to the use of the pyridyl heterocycles and hydro isomers thereof and/or pharmaceutical compositions comprising the compounds to treat or prevent HCV infections.
REFERENCES:
patent: 2852503 (1958-09-01), Edward et al.
patent: 3257203 (1966-06-01), Klupfel et al.
patent: 3335149 (1967-08-01), Preston
patent: 3910942 (1975-10-01), Narayanan et al.
patent: 3964896 (1976-06-01), Neidermyer et al.
patent: 4752324 (1988-06-01), Thomas et al.
patent: 5151441 (1992-09-01), Mueller et al.
patent: 5256666 (1993-10-01), Mueller et al.
patent: 5463071 (1995-10-01), Himmelsbach et al.
patent: 5814627 (1998-09-01), Schwab et al.
patent: 6355669 (2002-03-01), Yamauchi et al.
patent: 2002/0035156 (2002-03-01), Roniker et al.
patent: 2002/0049213 (2002-04-01), Weidner-Wells et al.
patent: 559 195 (1975-02-01), None
patent: 21 37 719 (1973-02-01), None
patent: 27 21 955 (1978-11-01), None
patent: 100 32 874 (2002-01-01), None
patent: 101 48 598 (2002-10-01), None
patent: 563686 (1993-03-01), None
patent: 0 776 894 (1997-06-01), None
patent: 92/7992 (1999-07-01), None
patent: 1 180 518 (2002-02-01), None
patent: 1 348 706 (2003-10-01), None
patent: 1 459 375 (1966-04-01), None
patent: 04124178 (1992-04-01), None
patent: WO 93/17671 (1993-09-01), None
patent: WO 94/17059 (1994-06-01), None
patent: WO 95/24397 (1995-09-01), None
patent: WO 98/17652 (1998-04-01), None
patent: WO 98/47509 (1998-10-01), None
patent: WO 99/04390 (1999-01-01), None
patent: WO 99/20309 (1999-04-01), None
patent: WO 02/20436 (2000-03-01), None
patent: WO 00/40242 (2000-07-01), None
patent: WO 00/45799 (2000-08-01), None
patent: WO 00/78726 (2000-12-01), None
patent: WO 01/74811 (2001-10-01), None
patent: WO 01/78648 (2001-10-01), None
patent: WO 02/46186 (2002-06-01), None
patent: WO 02/055025 (2002-07-01), None
patent: WO 03/029210 (2003-04-01), None
patent: WO 03/040112 (2003-05-01), None
patent: WO 04/018463 (2004-03-01), None
patent: WO 04/103366 (2004-12-01), None
Roth et al., “Zur Kondensation von Chalkonoxyden mit Hydroxylamin”,Arch. Pharm., vol. 94, pp. 769-774, 1961.
Samula, “Oksymowanic Azachalkonow”,Roczniki Chemll, Ann. Soc. Chim. Polonorum, vol. 45, pp. 2063, 1971.
Samula, “Cyclization of Azachalcones and β-Hydroxyketones Oximes”,Roczniki Chemll, Ann. soc. Chim, Polonorum, vol. 48, pp. 959-964, 1974.
Howe, et al., “Nitrile Oxide Cycloaddition Routes to 2-(Isoxazoly)-benzoates and 2-(1,2,4-Oxadiazol-3-yl)benzoates”,Heterocycl. Chem., vol. 19, No. 4, pp. 721-726, 1982.
Belgodere et al., “Studies on Isomeric Pyridylisoxazoles”,Heterocycles, vol. 20, No. 3, pp. 501-504, 1983.
Batori et al., “Photoinduced Ring Transformation of Pyrido[1,2-b]pyridazinium-4-olate”,Tetrehedron, vol. 50, No. 16, pp. 4699-4708, 1994.
Kanbara et al., “Preparation of Soluble and Fluorescent Poly(arylene)s by 1,3-Dipolar Polycycloaddition and Properties of the Polymers”,Polymer Bulletin, vol. 36, pp. 673-679, 1996.
Ku et al., “Use of Iodoacetylene as a Dipolarphile in the Synthesis of 5-Iodoisoxazole Derivatives”,Organic Letters, vol. 3, No. 26, pp. 4185-4187, 2001.
Maybridge, plc, Trevillett, Tintagel, Catalogue No. RF01972, Cornwall PL34 OHW, England.
Maybridge, plc, Trevillett, Tintagel, Catalog No. RF01996, Cornwall PL34 OHW, England.
Gatta et al, “Synthesis of [1,2,4]Triazoloquinazoline and [1,2,4]Triazolo-1,4-benzodiazepine derivatives”,J. Heterocyclic. Chem., vol. 30, pp. 11-16, 1993.
International Search Report.
Gatta et al. Synthesis of [1,2,4] Triazoloquinazoline and [1,2,4] Triazolo- 1,4-benzodiazepine derivatives. Journal of Heterocyclic Chemistry. (1993), vol. 30, pp. 11-16.
Database Chemcats Online! 1999m XP-002310049, Databased accession No. RN 247059-16-1.
Maybridge Hts, Order No. BTB 09742; RN 247059-16-1 Maybridge PLC, Trevillett, Tintagel, Cornwall, PL340HW, UK, Jan. 8, 2004 XP002297442.
STN File CA, Abstract 135:46129 & V.M. Barot et al, Asian Journal of Chemistry (2001), 13(1), pp. 341-343.
STN File CA, Abstract 132:265141 & S.V. Damle et al, Indian Journal of Heterocyclic Chemistry (1999), 9(2), pp. 81-86.
STN File CA, Abstract 132:180505 & V.R. Naik et al, Asian Journal of Chemistry (2000), 12(1), pp. 305-307.
STN File CA, Abstract 129:216539 & S.M. Naik et al, Oriental Journal of Chemistry (1998), 14(1), pp. 167-168.
STN File CA, Abstract 126:74789 & M. Shah et al, Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1996), 35B(12), pp. 1282-1286.
STN File CA, Abstract 122:81186 & S.R. Modi et al, Oriental Journal of Chemistry (1994), 10(1), pp. 85-86.
STN File CA, Abstract 118:191597 & T. Bandiera et al, Journal of Heterocyclic Chemistry (1992), 29(6), pp. 1423-1428.
Goff Dane
Lu Henry H.
Partridge John
Singh Rajinder
Davis Zinna N.
McDonnell Boehnen & Hulbert & Berghoff LLP
Rigel Pharmaceuticals Inc.
LandOfFree
Pyridyl substituted heterocycles useful for treating or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridyl substituted heterocycles useful for treating or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridyl substituted heterocycles useful for treating or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3739821